Drug Safety Concerns Prompt GAO Probe Of FDA
Amid recent safety concerns over two blockbuster drugs, the U.S. Government Accountability Office is set to investigate whether the U.S. Food and Drug Administration improperly cleared the medications without sufficient proof...To view the full article, register now.
Already a subscriber? Click here to view full article